Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New RVC study on managing canine epilepsy
The study found that clearer expectations about treatment outcomes help to improve the vet-owner relationship.
Researchers investigated the role of vet-owner relationships.

A new study from researchers at the Royal Veterinary College (RVC) has identified several key factors that can impact the relationship between the owners of dogs with idiopathic epilepsy and their veterinary surgeons.

These factors are not only likely to influence owner satisfaction with the care their dog is receiving, but they also increase adherence to care instructions.  

One key finding was the importance of providing owners with clear expectations from the first consultation about the condition. In general, owners had little previous experience or knowledge of canine epilepsy, and wanted more precise information on what to expect about disease progression and the effectiveness of treatment.

Other important factors identified as having a positive impact were repeated consultations with the same veterinary surgeon, good communication skills, up-to-date knowledge of epilepsy, and openness to owners contributing to discussions about treatment plans.

The findings, published in Vet Record, were based on face-to-face interviews with 21 owners of dogs with epilepsy.

As well as finding more about how to improve the relationship between owners and veterinary surgeons, the study also revealed that owners with a pre-existing negative view of veterinary professionals were more likely to conduct their own research into treatment and be influenced by misinformation online.

More than 60,000 dogs in the UK have canine epilepsy, making it the most common chronic neurological disease in dogs.

Dr Rowena Packer, primary supervisor on the study, said: “Epilepsy is a challenging condition to manage for dog owners and veterinary surgeons alike. Owners’ emotions often run high due to the trauma of witnessing their beloved dog’s seizure, and the ongoing stresses of caregiving for their dog. In tandem, vets can feel frustrated at not always being able to reduce seizures as much as they’d hope. Combined, the capacity for disappointment and conflict is high.

“Forging strong, trusting partnerships of care between owners and vets is key to maintaining wellbeing for all three members of the ‘treatment triangle’ – affected dogs, owners and vets. The first step towards this is striving for mutual understanding; the results of our novel study offers vets practical ways to achieve this.”

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.